I’m honored to serve as Guest Chief Medical Editor for this venous-focused edition of Endovascular Today. The contributors in this issue represent a multidisciplinary group of leaders who are ...

Venova Medical announced FDA investigational device exemption (IDE) approval to initiate the VENOS-3 pivotal study of the compan ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...